ArticleCommunications biology2025
Class A and B GPCRs trigger rapid Gα
Andréanne Laniel, Brian Holleran, Émy Labonté, Sarah-Janne Grondin, Pierre-Luc Boudreault, Christine Lavoie
Abstract read
In one paragraphArticle in Communications biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
6 authors.
Andréanne LanielInstitut de Pharmacologie de Sherbrooke, Department of Pharmacology and Physiology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Quebec, QC, Canada.
Brian HolleranInstitut de Pharmacologie de Sherbrooke, Department of Pharmacology and Physiology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Quebec, QC, Canada.
Émy LabontéInstitut de Pharmacologie de Sherbrooke, Department of Pharmacology and Physiology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Quebec, QC, Canada.
Sarah-Janne GrondinInstitut de Pharmacologie de Sherbrooke, Department of Pharmacology and Physiology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Quebec, QC, Canada.
Pierre-Luc BoudreaultInstitut de Pharmacologie de Sherbrooke, Department of Pharmacology and Physiology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Quebec, QC, Canada.ORCID http://orcid.org/0000-0002-2032-7970 Christine LavoieInstitut de Pharmacologie de Sherbrooke, Department of Pharmacology and Physiology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Quebec, QC, Canada. Christine.L.Lavoie@USherbrooke.ca.ORCID http://orcid.org/0000-0002-7673-5834 Funding
Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (Conseil de Recherches en Sciences Naturelles et en Génie du Canada) RGPIN-2020-06468
6 · The paper itselfAbstract
Indexed as
EndosomesGTP-Binding Protein alpha Subunits, GsReceptors, Adrenergic, beta-2Receptors, G-Protein-CoupledCell MembraneEndocytosisHEK293 CellsHumansProtein TransportSignal TransductionGTP-Binding Protein alpha Subunits, GsReceptors, Adrenergic, beta-2Receptors, G-Protein-Coupled
Identifiers
PMID41315746
PMCPMC12663142
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390